Long-Term, Real-World Safety of Adalimumab in Rheumatoid Arthritis

被引：0
|
作者：
Harrold, Leslie R. [1 ,2 ]
Griffith, Jenny [3 ]
Litman, Heather J. [2 ]
Gershenson, Bernice [1 ]
Islam, Syecl [3 ]
Barr, Christine J. [2 ]
Guo, Dianlin [3 ]
Zueger, Patrick [3 ]
Fay, Jonathan [3 ]
Greenberg, Jeffrey [2 ,4 ]
机构：
[1] Univ Massachusetts, Med Sch, Worcester, MA 01605 USA
[2] Corrona LLC, Waltham, MA USA
[3] AbbVie Inc, N Chicago, IL USA
[4] NYU, Sch Med, New York, NY USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2018年 / 70卷
关键词：
BIOLOGICS REGISTER;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1529
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Safety of adalimumab in long-term treatment of patients with rheumatoid arthritis
    Schiff, M
    Burmester, GR
    Kent, J
    Pangan, A
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P203 - P203
  • [2] REAL-WORLD HAWK STUDY: LONG-TERM SAFETY AND EFFECTIVENESS OF ADALIMUMAB WITH HIGHER-DOSE METHOTREXATE IN JAPANESE PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
    Tanaka, Y.
    Mimori, T.
    Yamanaka, H.
    Nakajima, R.
    Morita, K.
    Kimura, J.
    Takeuchi, T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 561 - 562
  • [3] Long-term treatment of rheumatoid arthritis with adalimumab
    Murdaca, Giuseppe
    Spano, Francesca
    Puppo, Francesco
    [J]. OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2013, 5 : 43 - 49
  • [4] Long-term safety of adalimumab (humira®) in worldwide rheumatoid arthritis clinical trials
    Schiff, MH
    Burmester, GR
    Pangan, A
    Kupper, H
    Spencer-Green, GT
    [J]. RHEUMATOLOGY, 2005, 44 : I70 - I71
  • [5] The Real-World Effectiveness, Persistence, Adherence, and Safety of Janus Kinase Inhibitor Baricitinib in Rheumatoid Arthritis: A Long-Term Study
    Calvo-Garcia, Alberto
    Herraiz, Esther Ramirez
    Cubas, Irene Maria Llorente
    De Dios, Blanca Varas
    Gonzalez, Juana Benedi
    Baladron, Alberto Morell
    Garcia-Vicuna, Rosario
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (09)
  • [6] Prevalence and predictors of long-term remission in rheumatoid arthritis in real-world practice: a longitudinal study
    Alireza Khabbazi
    Leyla Gadakchi
    Mohammadreza Moslemi
    Amirreza Khalaji
    Kamal Esalatmanesh
    Asma Ziarati Yazdeli
    Mehrzad Hajialilo
    Aida Malek Mahdavi
    [J]. Clinical Rheumatology, 2023, 42 : 1537 - 1544
  • [7] REAL-WORLD EXPERIENCE OF DOSE TAPERING TNF INHIBITORS IN RHEUMATOID ARTHRITIS: LONG-TERM RESULTS
    Lwin, May Nwe
    Nooh, Noor
    Holroyd, Christopher R.
    Lin, Sharon X.
    Culliford, David
    Fraser, Simon D.
    Edwards, Christopher J.
    [J]. RHEUMATOLOGY, 2023, 62
  • [8] Prevalence and predictors of long-term remission in rheumatoid arthritis in real-world practice: a longitudinal study
    Khabbazi, Alireza
    Gadakchi, Leyla
    Moslemi, Mohammadreza
    Khalaji, Amirreza
    Esalatmanesh, Kamal
    Ziarati Yazdeli, Asma
    Hajialilo, Mehrzad
    Malek Mahdavi, Aida
    [J]. CLINICAL RHEUMATOLOGY, 2023, 42 (06) : 1537 - 1544
  • [9] Long-term data for adalimumab in severe rheumatoid arthritis
    Keystone, Edward
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2011, 72 (12) : 668 - 668
  • [10] THE REAL-WORLD SAFETY OF RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Hyrich, Kimme
    [J]. RHEUMATOLOGY, 2017, 56 : 24 - 25
12345